Lawmakers introduce bill for generic labeling

A bipartisan group of lawmakers introduced the Patient Safety and Generic Labeling Improvement Act, which would allow generic drug manufacturers the ability to independently change a drug's label to provide up-to-date warnings to consumers. Under current federal regulations, only the branded manufacturer can change a drug's label. Last June, the U.S. Supreme Court ruled in Pliva Inc., et al. v. Mensing that patients harmed by inadequate warnings on generic drugs cannot sue the manufacturer for damages because the manufacturer is unable to update the label (see BioCentury Extra, June 23, 2011). ...